Menu
Surgical Intervention
Minor Clinic Intervention
Minor Clinic Intervention Invasive Day Surgery / Outpatient

Arteriovenous Fistula (AVF) Creation (Radiocephalic/Brachiocephalic)

Protocol / Details

Assess vessels via ultrasound mapping to select optimal site. Prepare the operative field under sterile conditions. Administer local anesthesia (lidocaine 2%). Perform longitudinal incision over the cephalic vein and adjacent artery. Mobilize the cephalic vein and perform end-to-side or side-to-side anastomosis using 6-0 or 7-0 non-absorbable monofilament sutures. Confirm palpable thrill upon clamp removal. Ensure hemostasis and close the skin with interrupted sutures.

Procedure Type
Surgery / Invasive
Estimated Base Cost
Varies by patient
Medical & Surgical Disclaimer The clinical information provided regarding this procedure is for educational purposes only. Only a qualified specialist or surgeon can determine if you are a suitable candidate for this intervention after a thorough examination.

Verify patient identity and site marking. Confirm coagulation profile (INR/PT) is within safe limits. Review ultrasound vessel mapping. Administer prophylactic antibiotics if indicated. Ensure patient has fasted for 2 hours. Secure informed consent.

Apply light compression dressing. Monitor for thrill and signs of hematoma for 30 minutes. Provide wound care instructions, warning signs of infection, and site protection guidelines. Patient discharged same day. Schedule follow-up for suture removal in 7-10 days.

Comprehensive Clinical Guide: Arteriovenous Fistula (AVF) Creation

Arteriovenous Fistula (AVF) creation remains the gold standard for vascular access in patients requiring long-term hemodialysis. By surgically connecting a native artery to a native vein, clinicians facilitate the high-flow requirements necessary for efficient blood filtration. This guide provides an exhaustive clinical overview of the radiocephalic and brachiocephalic AVF procedures.


1. Introduction and Overview

An Arteriovenous Fistula (AVF) is a surgical connection created between an artery and a vein, typically in the upper extremity. This connection causes blood to flow directly from the artery into the vein, bypassing the capillary system. The resulting increase in pressure and flow volume causes the vein to dilate and its wall to thicken—a process known as "maturation." Once matured, the vein is capable of withstanding the repeated needle punctures required for hemodialysis.

The two most common types of native AVFs are:
* Radiocephalic AVF (Cimino-Brescia): Connecting the radial artery to the cephalic vein at the wrist.
* Brachiocephalic AVF: Connecting the brachial artery to the cephalic vein at the antecubital fossa.


2. Technical Specifications and Mechanisms

The success of an AVF relies on physiological adaptation. The surgical anastomosis creates a high-flow environment that triggers vascular remodeling.

Hemodynamic Principles

Parameter Mechanism Result
Shear Stress Increased flow velocity Upregulation of nitric oxide; vasodilation
Wall Tension Increased transmural pressure Smooth muscle cell hypertrophy
Maturation Vessel wall remodeling Thickened, easily cannulatable vein

Surgical Configuration

  • End-to-Side: The most common configuration, where the end of the vein is sutured into the side of the artery. This minimizes the risk of distal limb ischemia.
  • Side-to-Side: Rarely used now due to the high risk of venous hypertension in the distal extremity (steal syndrome).
  • End-to-End: Occasionally used in specific anatomical variations, though it sacrifices distal arterial flow.

3. Clinical Indications and Usage

AVF creation is indicated for patients with Stage 4 or 5 Chronic Kidney Disease (CKD) who are approaching the need for Renal Replacement Therapy (RRT).

Indications for Surgery

  • eGFR < 20 mL/min/1.73m²: The "rule of thumb" for planning access.
  • Vascular Mapping: Pre-operative ultrasound (duplex mapping) is mandatory to ensure venous diameter is ≥ 2.5 mm and arterial diameter is ≥ 2.0 mm.
  • Failure of Prior Access: Revision or creation of a new fistula due to stenosis or thrombosis of previous access.

Patient Selection Criteria

  1. Vascular Anatomy: Absence of significant stenosis in the central veins or feeding arteries.
  2. Life Expectancy: Patients with a prognosis of > 1 year benefit most from native AVFs.
  3. Cardiac Status: Patients with severe heart failure must be evaluated for high-output cardiac failure risk before AVF creation.

4. Risks, Side Effects, and Contraindications

While superior to synthetic grafts (AVGs) or central venous catheters (CVCs), AVFs are not without risk.

Potential Complications

  • Access Thrombosis: The most common cause of AVF failure, often secondary to intimal hyperplasia.
  • Steal Syndrome: Arterial blood is diverted away from the distal limb, leading to coldness, pain, and ischemic tissue changes.
  • High-Output Heart Failure: If the fistula flow is too high relative to cardiac output.
  • Infection: Less common than with catheters, but possible.
  • Aneurysm/Pseudoaneurysm: Dilatation of the venous segment due to repeated cannulation or wall weakness.

Contraindications

  • Severe Peripheral Arterial Disease (PAD): May lead to critical limb ischemia.
  • Central Venous Stenosis: Prevents the return of blood to the heart.
  • Active Sepsis: Contraindicates any elective surgical procedure.

5. Pre-operative Preparation and Procedure

Pre-operative Protocol

  1. Vessel Mapping: Mandatory ultrasound to determine the best site.
  2. Mapping of Veins: Avoidance of veins previously used for blood draws or IV infusions.
  3. Antibiotic Prophylaxis: Typically a single dose of a first-generation cephalosporin.
  4. Informed Consent: Detailed discussion regarding the risk of failure and the need for secondary procedures.

Intra-operative Steps

  1. Anesthesia: Local anesthesia with sedation or regional nerve block (brachial plexus block).
  2. Incision: Longitudinal or curvilinear incision over the target vessels.
  3. Dissection: Careful mobilization of the artery and vein, minimizing handling to prevent vasospasm.
  4. Anastomosis: Application of vascular clamps, followed by a fine-suture (e.g., 6-0 or 7-0 Prolene) end-to-side anastomosis.
  5. Assessment: Release of clamps to assess for a strong "thrill" (palpable vibration) and audible "bruit" (continuous flow sound).

6. Post-operative Recovery and Maturation

Immediate Post-op (0-48 hours)

  • Elevation: Keep the arm elevated to reduce edema.
  • Neurovascular Checks: Monitor for signs of distal ischemia (capillary refill, sensation, motor function).
  • Thrill Assessment: Patient should be educated to feel for the vibration at least twice daily.

Maturation Phase (6-8 weeks)

  • Hand Exercises: Squeezing a rubber ball to promote venous dilation.
  • Avoidance of Trauma: No blood pressure cuffs or tight clothing on the access arm.
  • Ultrasound Surveillance: A 6-week follow-up scan is recommended to confirm sufficient diameter and flow rate (>600 mL/min) before first cannulation.

7. Alternative Treatments

When a native AVF is not feasible, alternative methods are required:
* Arteriovenous Graft (AVG): A synthetic tube (PTFE) connects the artery to the vein. These mature faster but have higher infection and thrombosis rates.
* Tunneled CVC: A temporary bridge, but associated with high rates of bacteremia and mortality.
* Endovascular AVF (endoAVF): A newer technique using catheter-based systems to create an anastomosis without an open incision.


8. Frequently Asked Questions (FAQ)

1. How long does an AVF last?
With proper care, a native AVF can last for many years, often outperforming synthetic grafts.

2. Can I exercise with an AVF?
Yes, light exercise is encouraged. Avoid heavy lifting or direct impact on the access site.

3. What is a "thrill" and why is it important?
A thrill is a vibration caused by high-flow blood. It is the best sign that your fistula is functioning correctly.

4. What should I do if the thrill disappears?
Contact your vascular access center immediately. This is a medical emergency that may indicate thrombosis.

5. Why is my arm swollen after surgery?
Mild swelling is normal. However, if it is severe or accompanied by pain, consult your surgeon to rule out venous outflow obstruction.

6. Can I sleep on the arm with the AVF?
No. Avoid compressing the fistula, as this can lead to clotting.

7. How do I know if I have Steal Syndrome?
Symptoms include pain, coldness, or numbness in the hand/fingers, especially during dialysis.

8. Is the surgery painful?
Most patients report minimal pain post-operatively, manageable with over-the-counter analgesics.

9. Why do I need an ultrasound before the procedure?
It ensures that your vessels are healthy enough to support the high flow required for dialysis.

10. Can I shower after the surgery?
Usually, you can shower after 48 hours, but keep the incision site dry and covered until the sutures are removed.


9. Conclusion

The creation of an Arteriovenous Fistula is a foundational procedure in nephrology, directly impacting the quality of life and survival of patients with end-stage renal disease. Success hinges on a multidisciplinary approach involving vascular surgeons, interventional radiologists, and dialysis nurses. By adhering to standardized pre-operative mapping, meticulous surgical technique, and vigilant post-operative monitoring, clinicians can maximize the longevity and efficacy of the dialysis access.

Summary Table: AVF vs. AVG

Feature Native AVF Synthetic AVG
Infection Risk Low Higher
Thrombosis Risk Lower Higher
Maturation Time 6–12 weeks 2–3 weeks
Longevity Excellent Moderate

Disclaimer: This guide is for educational purposes for medical professionals. Always consult institutional protocols and clinical guidelines (such as the KDOQI guidelines) for patient-specific management.

Share this procedure: